177 Efficacy of niraparib by timing of surgery and residual disease: a post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Autor: C McCormick, Tally Levy, F Selle, I Malinowska, Shahin, I Tusquets, Antonio González-Martín, F Joly, Richard G. Moore, Divya Gupta, Christof Vulsteke, William H. Bradley, David M. O'Malley, Bradley J. Monk, JA Pérez-Fidalgo, Roisin E. O'Cearbhaill, G Artioli, Sakari Hietanen, Klaus Baumann, Brian M. Slomovitz

Publikováno v: Ovarian cancer.

Introduction/Background* Niraparib is a poly(ADP-ribose) polymerase (PARP) inhibitor approved as maintenance treatment for patients (pts) with newly diagnosed advanced or recurrent ovarian cancer following a response to platinum-based chemotherapy (C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55222ee72a4a24354cf6ad8e5f13e2b5
https://doi.org/10.1136/ijgc-2021-esgo.349

Association of derived neutrophil-to-lymphocyte ratio (dNLR) with pathological complete response (pCR) after neoadjuvant chemotherapy (CT)

Autor: Lourdes Calvo, I. Tusquets Trias Bes, Emiliano Zamora de Alba, P. Valagussa, Antonio Antón, Jesús Herranz, Ainhara Lahuerta, Mauro Mansutti, A. Lluch, Giancarlo Bisagni, Begoña Bermejo, L. Gianni, Serafin Morales, Massimo Chiesa, Jil-M Chacón, Marc Thill, Vladimir Semiglazov, Joan Albanell, Alberto Ocaña, A. Chan

Publikováno v: Web of Science

Background dNLR is a novel biomarker associated with clinical outcome in solid tumors including early stage breast cancer (BC). Here we report the association of dNLR with pCR in triple-negative (TN) and luminal BC patients (pts) treated with neoadju

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c47d881ef1171b12fec9a77184fd8c
https://doi.org/10.1093/annonc/mdz240.094

271P - Association of derived neutrophil-to-lymphocyte ratio (dNLR) with pathological complete response (pCR) after neoadjuvant chemotherapy (CT)

Autor: Ocaña, A., Chacón, JIL-M, Calvo, L., Antón, A., Mansutti, M., Alba, E., Lluch, A., Lahuerta, A., Bisagni, G., Bermejo, B., Semiglazov, V., Thill, M., Chan, A., Morales, S., Albanell, J., Herranz, J., Trias Bes, I Tusquets, Valagussa, P., Chiesa, M., Gianni, L.

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v91-v92

Current controversies in the management of breast cancer

Autor: I, Tusquets, L, García-Estévez, E, Adrover, L, Calvo, I, Alvarez, J, García Mata, Y, Fernández, M, Margueli, M A, Seguí, M, Muñoz, C, Rodríguez, A, Rodríguez Lescure, R, Colomer, P, Gascón, M, Martín, E, Alba, A, Barnadas, A, Llombart, J, Albanell, A, Lluch

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

The following manuscript summarises the content of the Breast Symposium that was held in May 2008 in Barcelona in which four controversies regarding the management of breast cancer were discussed. The design of the symposium included two speakers per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6e2318f4955a2d2e64d0ba403127ce
https://pubmed.ncbi.nlm.nih.gov/20462837

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.